Simplify Logo

Full-Time

Pilot Plant Senior Manager

Confirmed live in the last 24 hours

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Data & Analytics
Hardware
AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$139k - $173.8kAnnually

+ Equity + Annual Bonus

Senior, Expert

Vancouver, BC, Canada

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • 8-12 years of industrial experience in process development, manufacturing, and/or MSAT, ideally working with antibodies, and a minimum of 4 years in a leadership role
  • bachelors or masters education in biotechnology, chemical/biochemical engineering, or another relevant life-science discipline
  • experience in scale-up, technology transfer, batch documentation and data management
  • demonstrated experience in leadership and managing direct reports including, developing and training teams to operate pilot scale manufacturing equipment
  • strong pilot-scale process and product data analysis skills, and practical experience for the establishment of processes and procedures for driving new investigational medicinal products forward
  • familiarity with regulatory requirements as it pertains to CMC activities for biologics (FDA, EMA, ICH, etc). Experience authoring regulatory filings such as INDs, BLAs, IMPDs etc. would be advantageous
  • passion for developing people and teams, and a proven track record establishing process development and/or manufacturing capabilities
  • thrive in a fast-paced environment with a high level of urgency and evolving priorities, and apply pragmatic, risk-based decision making to process development and manufacturing
Responsibilities
  • Providing strategic, technical and tactical leadership within the manufacturing, science & technology team through oversight of a 200L scale pilot manufacturing facility
  • Providing technical and scientific expertise and leadership for process optimization, scale-up, technology transfer and troubleshooting
  • Providing scientific leadership and project management for multiple early stage development projects
  • Championing high safety standards within the pilot plant
  • Detailed planning, coordination, implementation, tracking and communication to ensure material delivery whilst maintaining the production schedule for all technical pilot plant operations
  • Taking ownership and responsibility for the successful completion (as measured by product yield, quality & consistency, and the achievement of project timelines) of manufacturing campaigns
  • Providing a science-based approach for the evaluation and testing of new technologies / equipment to reduce cost of goods and streamline process development and manufacturing
  • Implementing and overseeing a robust equipment management and maintenance system, including oversight of and interaction with the site based support functions including the facility engineering and metrology teams
  • Overseeing supply chain needs of the pilot plant, including working with materials management on ensuring critical supplies are available and in stock as well as, being the point person for new equipment or supplies required for new technology transfers into the pilot plant

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

2%

1 year growth

0%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.